Low-dose Aspirin Seen to Reduce Amyloid Aggregates in Mouse Brains, Study Shows

Low-dose Aspirin Seen to Reduce Amyloid Aggregates in Mouse Brains, Study Shows
Treatment with low-dose aspirin was found to reduce the amount of brain amyloid aggregates that researchers believe are a hallmark of Alzheimer’s disease, according to a mouse study. These findings may open new therapeutic doors to prevent memory loss in Alzheimer’s patients. The study, “Aspirin induces Lysosomal biogenesis and attenuates Amyloid plaque pathology in a

Knowledge is power when living with alzheimers.

Get access to the web’s leading Alzheimer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

  1. DANTE MARCIANI says:

    If I recall well, some clinical studies using NSAID like aspirin did not show any benefits in slowing down the progression of AD. My question is, are these results limited to transgenic mouse models? After all, we should not forget that all of the drugs that have failed clinical studies were allowed to go into the clinical phase because of the promising results obtained with the transgenic models.

Leave a Comment

Your email address will not be published. Required fields are marked *